Key result
Obesity with metabolic syndrome was associated with significantly higher levels of atherogenic dyslipidemia, thrombotic, inflammatory, and oxidative stress biomarkers compared to overweight controls.
Why the study?
Obesity and metabolic syndrome are growing global public health problems, prompting assessment of differences in lipid, thrombotic, inflammatory, and oxidative stress markers between overweight and obese individuals.
Does obesity with metabolic syndrome worsen atherogenic dyslipidemia, thrombotic, inflammatory, and oxidative stress biomarkers compared to being overweight?
Case-Control (n=115)
Does obesity with metabolic syndrome worsen atherogenic dyslipidemia, thrombotic, inflammatory, and oxidative stress biomarkers compared to being overweight?
Answers are grounded in this paper and cite their sources.
Obesity combined with metabolic syndrome is associated with a significantly more atherogenic, inflammatory, and pro-thrombotic biomarker profile compared to being overweight alone.
Obesity and metabolic syndrome (MetS) are public health problems and are increasing globally. We assessed the differences in lipid profiles through lipid testing, thrombotic and inflammatory parameters, and oxidative stress indexes between overweight and obese patients with MetS in a Turkish adult population. We included 100 obese (body mass index [BMI] >30 kg/m 2 ) patients with MetS (66 women, 34 men, mean age 54.0 ± 10.1 years) and 15 overweight (BMI 25-30 kg/m 2 ) individuals (11 women, 4 men, mean age 50.2 ± 14.5 years) as controls. The group with MetS had significantly higher levels of glycaemia, uric acid, high-sensitivity C-reactive protein, homocysteine, fibrinogen, total cholesterol, low-density lipoprotein cholesterol (LDL-C), triglycerides, small dense LDL, oxidized LDL, apolipoprotein B (Apo B), lipoprotein (a), small and intermediate high-density lipoprotein (HDL) particles, oxidative stress index, and significantly lower levels of HDL-cholesterol (HDL-C), Apo A, and large HDL particles. In conclusion, obesity with MetS increase atherogenic dyslipidemia and thrombotic, inflammatory and oxidative stress biomarkers. Furthermore, obesity with MetS decreases protective mechanisms of atherosclerosis. We should at least try to prevent overweight individuals from becoming obese with MetS.
No takes yet. Share an insight, caveat, or question.
Bostan et al. (2020) conducted a case-control in Obesity and metabolic syndrome (n=115). Obesity with metabolic syndrome vs. Overweight (BMI 25-30 kg/m2) was evaluated on Lipid profiles, thrombotic and inflammatory parameters, and oxidative stress indexes. Obesity with metabolic syndrome was associated with significantly higher levels of atherogenic dyslipidemia, thrombotic, inflammatory, and oxidative stress biomarkers compared to overweight controls.
Synapse has enriched 10 related papers. Consider them for comparative context: